Bristol Advisors’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q4 | – | Sell |
-51,100
| Closed | -$174K | – | 76 |
|
2018
Q3 | $174K | Buy |
51,100
+50,000
| +4,545% | +$170K | 0.29% | 41 |
|
2018
Q2 | $4K | Hold |
1,100
| – | – | 0.01% | 48 |
|
2018
Q1 | $4K | Sell |
1,100
-190,000
| -99% | -$691K | 0.01% | 24 |
|
2017
Q4 | $889K | Buy |
191,100
+168,650
| +751% | +$785K | 0.56% | 35 |
|
2017
Q3 | $251K | Buy |
+22,450
| New | +$251K | 0.25% | 56 |
|
2017
Q2 | – | Hold |
0
| – | – | – | 75 |
|